The US-based protein purification technology developer shifted its manufacturing base to North Carolina two years ago and has now secured three licences from NC State.

US-based protein purification technology developer LigaTrap Technologies has raised $1.5m in funding since 2016 and has now licensed three biopharmaceutical research patents from North Carolina State University (NC State), WRALTechWire reported on Monday.

The identity of the backers and the timing of the investments have not been disclosed.

The licences augment LigaTrap’s range of purification resins, used to help isolate proteins and antibodies from complex mixtures for research, therapeutic and diagnostic purposes.

The additional patents commercialise work by Ruben Carbonell…